{
  "2": [
    {
      "name": "CB1",
      "type": "checkbox",
      "page": 2,
      "field_label": "Start of treatment",
      "question": "Is this a new treatment start for the patient?",
      "context": "Treatment timeline section. Indicates initiation of new therapy for patient. Dependent on CB5."
    },
    {
      "name": "T2",
      "type": "text",
      "page": 2,
      "field_label": "Start date: (MM)",
      "question": "What is the month of the treatment start date?",
      "context": "Treatment timeline section. Month of planned medication initiation for patient. Only if 'Start of treatment' selected."
    },
    {
      "name": "T3",
      "type": "text",
      "page": 2,
      "field_label": "Start date: (DD)",
      "question": "What is the day of the treatment start date?",
      "context": "Treatment timeline section. Day of planned medication initiation for patient. Only if 'Start of treatment' selected."
    },
    {
      "name": "T4",
      "type": "text",
      "page": 2,
      "field_label": "Start date: (YYYY)",
      "question": "What is the year of the treatment start date?",
      "context": "Treatment timeline section. Year of planned medication initiation for patient. Only if 'Start of treatment' selected."
    },
    {
      "name": "CB5",
      "type": "checkbox",
      "page": 2,
      "field_label": "Continuation of therapy",
      "question": "Is this a continuation of therapy for the patient?",
      "context": "Treatment timeline section. Indicates ongoing therapy for patient. Dependent on CB1."
    },
    {
      "name": "T6",
      "type": "text",
      "page": 2,
      "field_label": "Date of last treatment: (MM)",
      "question": "What is the month of the patient's last treatment date?",
      "context": "Treatment timeline section. Month of most recent treatment for patient. Only if 'Continuation of therapy' selected."
    },
    {
      "name": "T7",
      "type": "text",
      "page": 2,
      "field_label": "Date of last treatment: (DD)",
      "question": "What is the day of the patient's last treatment date?",
      "context": "Treatment timeline section. Day of most recent treatment for patient. Only if 'Continuation of therapy' selected."
    },
    {
      "name": "T8",
      "type": "text",
      "page": 2,
      "field_label": "Date of last treatment: (YYYY)",
      "question": "What is the year of the patient's last treatment date?",
      "context": "Treatment timeline section. Year of most recent treatment for patient. Only if 'Continuation of therapy' selected."
    },
    {
      "name": "T9",
      "type": "text",
      "page": 2,
      "field_label": "Precertification Requested By:",
      "question": "Who is requesting this precertification?",
      "context": "General information section. Identifies the individual or entity submitting the prior authorization request."
    },
    {
      "name": "T10",
      "type": "text",
      "page": 2,
      "field_label": "Phone:",
      "question": "What is the phone number for the precertification requester?",
      "context": "General information section. Contact details for the precertification requester for follow-up."
    },
    {
      "name": "T11",
      "type": "text",
      "page": 2,
      "field_label": "Fax:",
      "question": "What is the fax number for the precertification requester?",
      "context": "General information section. Contact details for the precertification requester for document submission."
    },
    {
      "name": "T12",
      "type": "text",
      "page": 2,
      "field_label": "Patient First Name",
      "question": "What is the patient's first name?",
      "context": "Patient Information section. Essential demographic data for patient identification."
    },
    {
      "name": "T13",
      "type": "text",
      "page": 2,
      "field_label": "Patient Last Name",
      "question": "What is the patient's last name?",
      "context": "Patient Information section. Essential demographic data for patient identification."
    },
    {
      "name": "T14",
      "type": "text",
      "page": 2,
      "field_label": "Patient DOB (MM/DD/YYYY)",
      "question": "What is the patient's date of birth (MM/DD/YYYY)?",
      "context": "Patient Information section. Crucial demographic data for age verification and patient matching."
    },
    {
      "name": "T15",
      "type": "text",
      "page": 2,
      "field_label": "Address:",
      "question": "What is the patient's street address?",
      "context": "Patient Information section. Required residential address for patient contact and records."
    },
    {
      "name": "T16",
      "type": "text",
      "page": 2,
      "field_label": "City:",
      "question": "What is the patient's city of residence?",
      "context": "Patient Information section. Required city for the patient's residential address."
    },
    {
      "name": "T17",
      "type": "text",
      "page": 2,
      "field_label": "State:",
      "question": "What is the patient's state of residence?",
      "context": "Patient Information section. Required state for the patient's residential address."
    },
    {
      "name": "T18",
      "type": "text",
      "page": 2,
      "field_label": "ZIP:",
      "question": "What is the patient's ZIP code?",
      "context": "Patient Information section. Required ZIP code for the patient's residential address."
    },
    {
      "name": "T19",
      "type": "text",
      "page": 2,
      "field_label": "Patient Phone",
      "question": "What is the patient's home phone number?",
      "context": "Patient Information section. Primary contact number for the patient."
    },
    {
      "name": "T20",
      "type": "text",
      "page": 2,
      "field_label": "Work Phone:",
      "question": "What is the patient's work phone number?",
      "context": "Patient Information section. Secondary contact phone number for the patient."
    },
    {
      "name": "T21",
      "type": "text",
      "page": 2,
      "field_label": "Cell Phone:",
      "question": "What is the patient's cell phone number?",
      "context": "Patient Information section. Mobile contact number for the patient."
    },
    {
      "name": "T22",
      "type": "text",
      "page": 2,
      "field_label": "E-mail:",
      "question": "What is the patient's email address?",
      "context": "Patient Information section. Electronic contact information for the patient."
    },
    {
      "name": "T24",
      "type": "text",
      "page": 2,
      "field_label": "lbs",
      "question": "What is the patient's current weight in pounds?",
      "context": "Patient Information section. Patient's current weight, used for medication dosing calculations."
    },
    {
      "name": "T25",
      "type": "text",
      "page": 2,
      "field_label": "kgs",
      "question": "What is the patient's current weight in kilograms?",
      "context": "Patient Information section. Patient's current weight, used for medication dosing calculations."
    },
    {
      "name": "T26",
      "type": "text",
      "page": 2,
      "field_label": "inches",
      "question": "What is the patient's height in inches?",
      "context": "Patient Information section. Patient's height, used for body surface area calculations for dosing."
    },
    {
      "name": "T27",
      "type": "text",
      "page": 2,
      "field_label": "cms",
      "question": "What is the patient's height in centimeters?",
      "context": "Patient Information section. Patient's height, used for body surface area calculations for dosing."
    },
    {
      "name": "T23",
      "type": "text",
      "page": 2,
      "field_label": "Allergies:",
      "question": "Does the patient have any known allergies? If so, please list them.",
      "context": "Patient Information section. Critical clinical information for patient safety and medication selection."
    },
    {
      "name": "T28",
      "type": "text",
      "page": 2,
      "field_label": "Member ID #:",
      "question": "What is the patient's insurance member ID number?",
      "context": "Insurance Information section. Primary identifier for the patient under their health plan."
    },
    {
      "name": "T29",
      "type": "text",
      "page": 2,
      "field_label": "Group #:",
      "question": "What is the patient's insurance group number?",
      "context": "Insurance Information section. Identifies the group policy the patient is covered under."
    },
    {
      "name": "T30",
      "type": "text",
      "page": 2,
      "field_label": "Insured:",
      "question": "What is the name of the primary insured party?",
      "context": "Insurance Information section. Identifies the policyholder, if different from the patient."
    },
    {
      "name": "CB31",
      "type": "checkbox",
      "page": 2,
      "field_label": "Yes",
      "question": "Does the patient have other health coverage?",
      "context": "Insurance Information section. Determines if coordination of benefits is required due to multiple coverages."
    },
    {
      "name": "CB32",
      "type": "checkbox",
      "page": 2,
      "field_label": "No",
      "question": "Does the patient not have other health coverage?",
      "context": "Insurance Information section. Determines if coordination of benefits is required due to multiple coverages."
    },
    {
      "name": "T33",
      "type": "text",
      "page": 2,
      "field_label": "If yes, provide ID#:",
      "question": "If the patient has other coverage, what is the ID number for that coverage?",
      "context": "Insurance Information section. Sub-question dependent on CB31 (Yes). Provides ID for secondary insurance."
    },
    {
      "name": "T34",
      "type": "text",
      "page": 2,
      "field_label": "Carrier Name:",
      "question": "What is the name of the patient's other insurance carrier?",
      "context": "Insurance Information section. Sub-question dependent on CB31 (Yes). Identifies the secondary insurance provider."
    },
    {
      "name": "T35",
      "type": "text",
      "page": 2,
      "field_label": "Insured:",
      "question": "What is the name of the primary insured party for the other coverage?",
      "context": "Insurance Information section. Sub-question dependent on CB31 (Yes). Identifies secondary policyholder."
    },
    {
      "name": "T42",
      "type": "text",
      "page": 2,
      "field_label": "First Name:",
      "question": "What is the prescriber's first name?",
      "context": "Prescriber Information section. Demographic data for the prescribing physician/provider."
    },
    {
      "name": "T43",
      "type": "text",
      "page": 2,
      "field_label": "Last Name:",
      "question": "What is the prescriber's last name?",
      "context": "Prescriber Information section. Demographic data for the prescribing physician/provider."
    },
    {
      "name": "CB44",
      "type": "checkbox",
      "page": 2,
      "field_label": "M.D.",
      "question": "Is the prescriber an M.D. (Medical Doctor)?",
      "context": "Prescriber Information section. Primary question for the prescriber's medical degree/license type."
    },
    {
      "name": "CB45",
      "type": "checkbox",
      "page": 2,
      "field_label": "D.O.",
      "question": "Is the prescriber a D.O. (Doctor of Osteopathic Medicine)?",
      "context": "Prescriber Information section. Primary question for the prescriber's medical degree/license type."
    },
    {
      "name": "CB46",
      "type": "checkbox",
      "page": 2,
      "field_label": "N.P.",
      "question": "Is the prescriber an N.P. (Nurse Practitioner)?",
      "context": "Prescriber Information section. Primary question for the prescriber's medical degree/license type."
    },
    {
      "name": "CB47",
      "type": "checkbox",
      "page": 2,
      "field_label": "P.A.",
      "question": "Is the prescriber a P.A. (Physician Assistant)?",
      "context": "Prescriber Information section. Primary question for the prescriber's medical degree/license type."
    },
    {
      "name": "T48",
      "type": "text",
      "page": 2,
      "field_label": "Address:",
      "question": "What is the prescriber's street address?",
      "context": "Prescriber Information section. Business address for the prescribing provider's practice."
    },
    {
      "name": "T49",
      "type": "text",
      "page": 2,
      "field_label": "City:",
      "question": "What is the prescriber's city?",
      "context": "Prescriber Information section. City for the prescribing provider's business address."
    },
    {
      "name": "T50",
      "type": "text",
      "page": 2,
      "field_label": "State:",
      "question": "What is the prescriber's state?",
      "context": "Prescriber Information section. State for the prescribing provider's business address."
    },
    {
      "name": "T51",
      "type": "text",
      "page": 2,
      "field_label": "ZIP:",
      "question": "What is the prescriber's ZIP code?",
      "context": "Prescriber Information section. ZIP code for the prescribing provider's business address."
    },
    {
      "name": "T52",
      "type": "text",
      "page": 2,
      "field_label": "Phone:",
      "question": "What is the prescriber's phone number?",
      "context": "Prescriber Information section. Primary contact number for the prescribing provider."
    },
    {
      "name": "T53",
      "type": "text",
      "page": 2,
      "field_label": "Fax:",
      "question": "What is the prescriber's fax number?",
      "context": "Prescriber Information section. Fax number for the prescribing provider's office."
    },
    {
      "name": "T54",
      "type": "text",
      "page": 2,
      "field_label": "St Lic #:",
      "question": "What is the prescriber's state license number?",
      "context": "Prescriber Information section. Professional license identifier for the prescribing provider."
    },
    {
      "name": "T55",
      "type": "text",
      "page": 2,
      "field_label": "NPI #:",
      "question": "What is the prescriber's NPI (National Provider Identifier) number?",
      "context": "Prescriber Information section. Unique identifier for healthcare providers used in HIPAA transactions."
    },
    {
      "name": "T56",
      "type": "text",
      "page": 2,
      "field_label": "DEA #:",
      "question": "What is the prescriber's DEA (Drug Enforcement Administration) number?",
      "context": "Prescriber Information section. Required for prescribing controlled substances."
    },
    {
      "name": "T57",
      "type": "text",
      "page": 2,
      "field_label": "UPIN:",
      "question": "What is the prescriber's UPIN (Unique Physician Identification Number)?",
      "context": "Prescriber Information section. Former Medicare identifier; may still be requested for provider identification."
    },
    {
      "name": "T58.0",
      "type": "text",
      "page": 2,
      "field_label": "Provider Email:",
      "question": "What is the prescriber's email address?",
      "context": "Prescriber Information section. Electronic contact information for the prescribing provider."
    },
    {
      "name": "T58.1",
      "type": "text",
      "page": 2,
      "field_label": "Office Contact Name:",
      "question": "What is the name of the office contact person for the prescriber?",
      "context": "Prescriber Information section. Name of a contact person at the prescriber's office."
    },
    {
      "name": "T59",
      "type": "text",
      "page": 2,
      "field_label": "Phone:",
      "question": "What is the office contact person's phone number?",
      "context": "Prescriber Information section. Phone number for the office contact person for general inquiries."
    },
    {
      "name": "Provider Admin CB.1",
      "type": "checkbox",
      "page": 2,
      "field_label": "Self-administered",
      "question": "Will the medication be self-administered by the patient?",
      "context": "Dispensing/Administration Information section. Indicates how the medication will be administered to the patient."
    },
    {
      "name": "Provider Admin CB.2",
      "type": "checkbox",
      "page": 2,
      "field_label": "Physician’s Office",
      "question": "Will the medication be administered at the physician's office?",
      "context": "Dispensing/Administration Information section. Specifies the location of medication administration."
    },
    {
      "name": "Provider Admin CB.3",
      "type": "checkbox",
      "page": 2,
      "field_label": "Home",
      "question": "Will the medication be administered at home?",
      "context": "Dispensing/Administration Information section. Specifies the location of medication administration."
    },
    {
      "name": "Provider Admin CB.4",
      "type": "checkbox",
      "page": 2,
      "field_label": "Outpatient Infusion Center",
      "question": "Will the medication be administered at an outpatient infusion center?",
      "context": "Dispensing/Administration Information section. Specifies the location of medication administration."
    },
    {
      "name": "Provider Admin T.5",
      "type": "text",
      "page": 2,
      "field_label": "Name:",
      "question": "What is the name of the outpatient infusion center?",
      "context": "Dispensing/Administration Information section. Sub-question for specific outpatient infusion center details, if selected."
    },
    {
      "name": "Provider Admin CB.7",
      "type": "checkbox",
      "page": 2,
      "field_label": "Home Infusion Center",
      "question": "Will the medication be administered by a home infusion center?",
      "context": "Dispensing/Administration Information section. Specifies if medication administration occurs via home infusion."
    },
    {
      "name": "Provider Admin T.6",
      "type": "text",
      "page": 2,
      "field_label": "Phone:",
      "question": "What is the phone number for the home infusion center?",
      "context": "Dispensing/Administration Information section. Sub-question for specific home infusion center details, if selected."
    },
    {
      "name": "Provider Admin T.8",
      "type": "text",
      "page": 2,
      "field_label": "Agency Name:",
      "question": "What is the agency name for the home infusion center?",
      "context": "Dispensing/Administration Information section. Sub-question for specific home infusion center details, if selected."
    },
    {
      "name": "Provider Admin CB.10",
      "type": "checkbox",
      "page": 2,
      "field_label": "Administration code(s)",
      "question": "Will administration code(s) be provided for the medication?",
      "context": "Dispensing/Administration Information section. Indicates if CPT/HCPCS codes for administration will be included."
    },
    {
      "name": "Provider Admin T.9",
      "type": "text",
      "page": 2,
      "field_label": "CPT:",
      "question": "What are the CPT administration code(s)?",
      "context": "Dispensing/Administration Information section. Sub-question for specific CPT codes for medication administration."
    },
    {
      "name": "Provider Admin T.11A",
      "type": "text",
      "page": 2,
      "field_label": "Address:",
      "question": "What is the address for the administering facility/provider?",
      "context": "Dispensing/Administration Information section. Address for the facility where medication is administered."
    },
    {
      "name": "Provider Admin T.13",
      "type": "text",
      "page": 2,
      "field_label": "City:",
      "question": "What is the city for the administering facility/provider?",
      "context": "Dispensing/Administration Information section. City for the administering facility's address."
    },
    {
      "name": "Provider Admin T.14",
      "type": "text",
      "page": 2,
      "field_label": "State:",
      "question": "What is the state for the administering facility/provider?",
      "context": "Dispensing/Administration Information section. State for the administering facility's address."
    },
    {
      "name": "Provider Admin T.15",
      "type": "text",
      "page": 2,
      "field_label": "ZIP:",
      "question": "What is the ZIP code for the administering facility/provider?",
      "context": "Dispensing/Administration Information section. ZIP code for the administering facility's address."
    },
    {
      "name": "Provider Admin T.16",
      "type": "text",
      "page": 2,
      "field_label": "Phone:",
      "question": "What is the phone number for the administering facility/provider?",
      "context": "Dispensing/Administration Information section. Phone number for the administering facility."
    },
    {
      "name": "Provider Admin T.17A",
      "type": "text",
      "page": 2,
      "field_label": "Fax:",
      "question": "What is the fax number for the administering facility/provider?",
      "context": "Dispensing/Administration Information section. Fax number for the administering facility."
    },
    {
      "name": "Provider Admin T.18",
      "type": "text",
      "page": 2,
      "field_label": "TIN:",
      "question": "What is the Tax Identification Number (TIN) for the administering facility/provider?",
      "context": "Dispensing/Administration Information section. Financial identifier for the administering entity."
    },
    {
      "name": "Provider Admin T.19",
      "type": "text",
      "page": 2,
      "field_label": "PIN:",
      "question": "What is the Provider Identification Number (PIN) for the administering facility/provider?",
      "context": "Dispensing/Administration Information section. Unique identifier assigned by the payer to the provider."
    },
    {
      "name": "Provider Admin T.20",
      "type": "text",
      "page": 2,
      "field_label": "NPI:",
      "question": "What is the National Provider Identifier (NPI) for the administering facility/provider?",
      "context": "Dispensing/Administration Information section. Unique identifier for the healthcare provider/facility."
    },
    {
      "name": "Provider Admin CB.21",
      "type": "checkbox",
      "page": 2,
      "field_label": "Outpatient Dialysis Center",
      "question": "Will the medication be dispensed from an outpatient dialysis center?",
      "context": "Dispensing Provider Information section. Specifies source of dispensed medication for the patient."
    },
    {
      "name": "Provider Admin CB.22",
      "type": "checkbox",
      "page": 2,
      "field_label": "Physician’s Office",
      "question": "Will the medication be dispensed from a physician's office?",
      "context": "Dispensing Provider Information section. Specifies source of dispensed medication for the patient."
    },
    {
      "name": "Provider Admin CB.23.0.0",
      "type": "checkbox",
      "page": 2,
      "field_label": "Retail Pharmacy",
      "question": "Will the medication be dispensed from a retail pharmacy?",
      "context": "Dispensing Provider Information section. Specifies source of dispensed medication for the patient."
    },
    {
      "name": "Provider Admin CB.24.0.0",
      "type": "checkbox",
      "page": 2,
      "field_label": "Specialty Pharmacy",
      "question": "Will the medication be dispensed from a specialty pharmacy?",
      "context": "Dispensing Provider Information section. Specifies source of dispensed medication for the patient."
    },
    {
      "name": "Provider Admin CB.25",
      "type": "checkbox",
      "page": 2,
      "field_label": "Mail Order",
      "question": "Will the medication be dispensed via mail order?",
      "context": "Dispensing Provider Information section. Specifies source of dispensed medication for the patient."
    },
    {
      "name": "Provider Admin CB.26",
      "type": "checkbox",
      "page": 2,
      "field_label": "Other:",
      "question": "Will the medication be dispensed from another type of facility/provider not listed?",
      "context": "Dispensing Provider Information section. Catch-all option for other dispensing locations."
    },
    {
      "name": "Provider Admin T.27",
      "type": "text",
      "page": 2,
      "field_label": "Other:",
      "question": "If 'Other' dispensing location is selected, please specify.",
      "context": "Dispensing Provider Information section. Sub-question dependent on 'Other' checkbox. Details alternate dispensing location."
    },
    {
      "name": "Provider Admin T.28",
      "type": "text",
      "page": 2,
      "field_label": "Name:",
      "question": "What is the name of the dispensing provider/pharmacy?",
      "context": "Dispensing Provider Information section. Name of the entity dispensing the medication."
    },
    {
      "name": "Provider Admin T.29a",
      "type": "text",
      "page": 2,
      "field_label": "Address:",
      "question": "What is the street address of the dispensing provider/pharmacy?",
      "context": "Dispensing Provider Information section. Address of the entity dispensing the medication."
    },
    {
      "name": "Provider Admin T.30a",
      "type": "text",
      "page": 2,
      "field_label": "City:",
      "question": "What is the city of the dispensing provider/pharmacy?",
      "context": "Dispensing Provider Information section. City of the entity dispensing the medication."
    },
    {
      "name": "Provider Admin T.31",
      "type": "text",
      "page": 2,
      "field_label": "State:",
      "question": "What is the state of the dispensing provider/pharmacy?",
      "context": "Dispensing Provider Information section. State of the entity dispensing the medication."
    },
    {
      "name": "Provider Admin T.32",
      "type": "text",
      "page": 2,
      "field_label": "ZIP:",
      "question": "What is the ZIP code of the dispensing provider/pharmacy?",
      "context": "Dispensing Provider Information section. ZIP code of the entity dispensing the medication."
    },
    {
      "name": "Provider Admin T.33",
      "type": "text",
      "page": 2,
      "field_label": "Phone:",
      "question": "What is the phone number for the dispensing provider/pharmacy?",
      "context": "Dispensing Provider Information section. Phone number for the dispensing entity."
    },
    {
      "name": "Provider Admin T.34",
      "type": "text",
      "page": 2,
      "field_label": "Fax:",
      "question": "What is the fax number for the dispensing provider/pharmacy?",
      "context": "Dispensing Provider Information section. Fax number for the dispensing entity."
    },
    {
      "name": "Provider Admin T.35",
      "type": "text",
      "page": 2,
      "field_label": "TIN:",
      "question": "What is the Tax Identification Number (TIN) for the dispensing provider/pharmacy?",
      "context": "Dispensing Provider Information section. Financial identifier for the dispensing entity."
    },
    {
      "name": "Provider Admin T.36",
      "type": "text",
      "page": 2,
      "field_label": "PIN:",
      "question": "What is the Provider Identification Number (PIN) for the dispensing provider/pharmacy?",
      "context": "Dispensing Provider Information section. Unique identifier assigned by the payer to the dispensing entity."
    },
    {
      "name": "Provider Admin T.37",
      "type": "text",
      "page": 2,
      "field_label": "NPI:",
      "question": "What is the National Provider Identifier (NPI) for the dispensing provider/pharmacy?",
      "context": "Dispensing Provider Information section. Unique identifier for the dispensing entity."
    },
    {
      "name": "CB60",
      "type": "checkbox",
      "page": 2,
      "field_label": "Riabni (rituximab-arrx)",
      "question": "Is Riabni (rituximab-arrx) the requested product?",
      "context": "Product Information section. Identifies the specific Rituximab product requested for prior authorization."
    },
    {
      "name": "CB61",
      "type": "checkbox",
      "page": 2,
      "field_label": "Rituxan (rituximab)",
      "question": "Is Rituxan (rituximab) the requested product?",
      "context": "Product Information section. Identifies the specific Rituximab product requested for prior authorization."
    },
    {
      "name": "CB62",
      "type": "checkbox",
      "page": 2,
      "field_label": "Ruxience (rituximab-pvvr)",
      "question": "Is Ruxience (rituximab-pvvr) the requested product?",
      "context": "Product Information section. Identifies the specific Rituximab biosimilar requested for prior authorization."
    },
    {
      "name": "CB63",
      "type": "checkbox",
      "page": 2,
      "field_label": "Truxima (rituximab-abbs)",
      "question": "Is Truxima (rituximab-abbs) the requested product?",
      "context": "Product Information section. Identifies the specific Rituximab biosimilar requested for prior authorization."
    },
    {
      "name": "T64",
      "type": "text",
      "page": 2,
      "field_label": "Dose:",
      "question": "What is the requested dose of the medication?",
      "context": "Product Information section. Specifies the quantity of medication to be administered per dose."
    },
    {
      "name": "T65",
      "type": "text",
      "page": 2,
      "field_label": "Directions for Use:",
      "question": "What are the directions for using the requested medication?",
      "context": "Product Information section. Provides instructions for medication administration, including frequency and route."
    },
    {
      "name": "T66",
      "type": "text",
      "page": 2,
      "field_label": "HCPCS Code:",
      "question": "What is the HCPCS (Healthcare Common Procedure Coding System) code for the requested product/service?",
      "context": "Product Information section. Standardized code for medical procedures, services, or supplies."
    },
    {
      "name": "T67",
      "type": "text",
      "page": 2,
      "field_label": "Primary ICD Code:",
      "question": "What is the patient's primary ICD (International Classification of Diseases) code for their diagnosis?",
      "context": "Diagnosis Information section. Primary medical diagnosis code supporting the precertification request."
    },
    {
      "name": "CB68",
      "type": "checkbox",
      "page": 2,
      "field_label": "Other ICD Code:",
      "question": "Is there another ICD code applicable to the patient's diagnosis?",
      "context": "Diagnosis Information section. Indicates if additional diagnostic codes will be provided for clinical context."
    },
    {
      "name": "T69",
      "type": "text",
      "page": 2,
      "field_label": "Other ICD Code:",
      "question": "What is the patient's other applicable ICD code?",
      "context": "Diagnosis Information section. Sub-question dependent on CB68. Provides secondary diagnosis codes."
    },
    {
      "name": "CB70",
      "type": "checkbox",
      "page": 2,
      "field_label": "Yes",
      "question": "Has the patient had prior therapy with the requested product within the last 365 days?",
      "context": "Clinical Information (Initiation) section. Inquires about recent use of the requested drug for patient history."
    },
    {
      "name": "CB71",
      "type": "checkbox",
      "page": 2,
      "field_label": "No",
      "question": "Has the patient not had prior therapy with the requested product within the last 365 days?",
      "context": "Clinical Information (Initiation) section. Inquires about recent use of the requested drug for patient history."
    },
    {
      "name": "CB72",
      "type": "checkbox",
      "page": 2,
      "field_label": "No",
      "question": "Has the patient not had a trial and failure of any of the listed rituximab biosimilars?",
      "context": "Clinical Information (Initiation) section. Evaluates if patient has tried preferred biosimilars before requesting non-preferred."
    },
    {
      "name": "CB73",
      "type": "checkbox",
      "page": 2,
      "field_label": "Ruxience (rituximab-pvvr)",
      "question": "Has the patient had a trial and failure of Ruxience (rituximab-pvvr)?",
      "context": "Clinical Information (Initiation) section. Sub-question if patient failed specific preferred rituximab biosimilar."
    },
    {
      "name": "CB74",
      "type": "checkbox",
      "page": 2,
      "field_label": "Truxima (rituximab-abbs)",
      "question": "Has the patient had a trial and failure of Truxima (rituximab-abbs)?",
      "context": "Clinical Information (Initiation) section. Sub-question if patient failed specific preferred rituximab biosimilar."
    },
    {
      "name": "T75",
      "type": "text",
      "page": 2,
      "field_label": "When was the member’s trial and failure of the preferred drug?",
      "question": "When did the member's trial and failure of the preferred drug occur?",
      "context": "Clinical Information (Initiation) section. Date of unsuccessful treatment with a preferred biosimilar."
    },
    {
      "name": "T76",
      "type": "text",
      "page": 2,
      "field_label": "Please describe the nature of the failure of the preferred drug",
      "question": "Please describe the nature of the failure of the preferred drug for the patient.",
      "context": "Clinical Information (Initiation) section. Details clinical reason for prior preferred therapy failure (e.g., lack of efficacy)."
    },
    {
      "name": "CB77",
      "type": "checkbox",
      "page": 2,
      "field_label": "No",
      "question": "Has the patient not had an adverse reaction to any of the listed rituximab biosimilars?",
      "context": "Clinical Information (Initiation) section. Evaluates if patient had adverse reactions to preferred biosimilars."
    },
    {
      "name": "CB78",
      "type": "checkbox",
      "page": 2,
      "field_label": "Ruxience (rituximab-pvvr)",
      "question": "Has the patient had an adverse reaction to Ruxience (rituximab-pvvr)?",
      "context": "Clinical Information (Initiation) section. Sub-question if patient experienced adverse reaction to specific preferred biosimilar."
    },
    {
      "name": "CB79",
      "type": "checkbox",
      "page": 2,
      "field_label": "Truxima (rituximab-abbs)",
      "question": "Has the patient had an adverse reaction to Truxima (rituximab-abbs)?",
      "context": "Clinical Information (Initiation) section. Sub-question if patient experienced adverse reaction to specific preferred biosimilar."
    },
    {
      "name": "T80",
      "type": "text",
      "page": 2,
      "field_label": "When was the member’s adverse reaction to the preferred drug?",
      "question": "When did the member's adverse reaction to the preferred drug occur?",
      "context": "Clinical Information (Initiation) section. Date of adverse event with a preferred biosimilar, if applicable."
    },
    {
      "name": "T81",
      "type": "text",
      "page": 2,
      "field_label": "Please describe the nature of the adverse reaction to the preferred drug",
      "question": "Please describe the nature of the adverse reaction experienced by the patient to the preferred drug.",
      "context": "Clinical Information (Initiation) section. Details clinical reason for adverse reaction to previous preferred therapy."
    },
    {
      "name": "T84",
      "type": "text",
      "page": 2,
      "field_label": "Please explain if there are any contraindications or other medical reason(s) that the patient cannot use any of the following preferred biosimilar products when indicated for the patient’s diagnosis?",
      "question": "Are there any contraindications or medical reasons preventing the patient from using the preferred biosimilar products? If so, please explain.",
      "context": "Clinical Information (Initiation) section. Justification for not using preferred biosimilars due to medical necessity."
    },
    {
      "name": "CB82",
      "type": "checkbox",
      "page": 2,
      "field_label": "Ruxience (rituximab-pvvr)",
      "question": "Is Ruxience (rituximab-pvvr) contraindicated or medically unsuitable for the patient?",
      "context": "Clinical Information (Initiation) section. Sub-question for specific preferred biosimilar contraindication details."
    },
    {
      "name": "CB83",
      "type": "checkbox",
      "page": 2,
      "field_label": "Truxima (rituximab-abbs)",
      "question": "Is Truxima (rituximab-abbs) contraindicated or medically unsuitable for the patient?",
      "context": "Clinical Information (Initiation) section. Sub-question for specific preferred biosimilar contraindication details."
    }
  ],
  "3": [
    {
      "name": "T12",
      "type": "text",
      "page": 3,
      "field_label": "Patient First Name",
      "question": "What is the patient's first name?",
      "context": "Patient identification: first name of the individual for whom the prior authorization is being requested."
    },
    {
      "name": "T13",
      "type": "text",
      "page": 3,
      "field_label": "Patient Last Name",
      "question": "What is the patient's last name?",
      "context": "Patient identification: last name of the individual for whom the prior authorization is being requested."
    },
    {
      "name": "T19",
      "type": "text",
      "page": 3,
      "field_label": "Patient Phone",
      "question": "What is the patient's phone number?",
      "context": "Patient contact information: primary phone number for communication with the patient."
    },
    {
      "name": "T14",
      "type": "text",
      "page": 3,
      "field_label": "Patient DOB (MM/DD/YYYY)",
      "question": "What is the patient's date of birth?",
      "context": "Patient identification: date of birth (MM/DD/YYYY format) for demographic verification."
    },
    {
      "name": "CB86",
      "type": "checkbox",
      "page": 3,
      "field_label": "Inflectra (infliximab-dyyb)",
      "question": "Has the patient had a trial and failure of Inflectra (infliximab-dyyb)?",
      "context": "Clinical history: Indicates if a trial and failure of Inflectra, a preferred biosimilar, occurred for this initiation request."
    },
    {
      "name": "CB87",
      "type": "checkbox",
      "page": 3,
      "field_label": "Renflexis (infliximab-abda)",
      "question": "Has the patient had a trial and failure of Renflexis (infliximab-abda)?",
      "context": "Clinical history: Indicates if a trial and failure of Renflexis, a preferred biosimilar, occurred for this initiation request."
    },
    {
      "name": "CB88",
      "type": "checkbox",
      "page": 3,
      "field_label": "Simponi Aria (golimumab)",
      "question": "Has the patient had a trial and failure of Simponi Aria (golimumab)?",
      "context": "Clinical history: Indicates if a trial and failure of Simponi Aria, a preferred biologic, occurred for this initiation request."
    },
    {
      "name": "T89",
      "type": "text",
      "page": 3,
      "field_label": "When was the member’s trial and failure of the preferred drug?",
      "question": "When did the patient's trial and failure of the preferred drug occur?",
      "context": "Clinical history: Specifies the date of trial and failure, important for assessing recency and treatment progression. Dependent on prior checkbox selection."
    },
    {
      "name": "T90",
      "type": "text",
      "page": 3,
      "field_label": "Please describe the nature of the failure of the preferred drug",
      "question": "Describe the nature of the patient's failure with the preferred drug.",
      "context": "Clinical history: Details why the preferred drug failed (e.g., lack of efficacy, progression). Dependent on prior checkbox selection."
    },
    {
      "name": "CB85",
      "type": "checkbox",
      "page": 3,
      "field_label": "No",
      "question": "Has the patient NOT had a trial and failure of any specified rituximab biosimilars?",
      "context": "Clinical history: Indicates if the patient has not undergone trial and failure of the listed preferred drugs."
    },
    {
      "name": "CB92",
      "type": "checkbox",
      "page": 3,
      "field_label": "Inflectra (infliximab-dyyb)",
      "question": "Has the patient had an adverse reaction to Inflectra (infliximab-dyyb)?",
      "context": "Clinical history: Indicates if the patient experienced an adverse reaction to Inflectra, a preferred biosimilar."
    },
    {
      "name": "CB93",
      "type": "checkbox",
      "page": 3,
      "field_label": "Renflexis (infliximab-abda)",
      "question": "Has the patient had an adverse reaction to Renflexis (infliximab-abda)?",
      "context": "Clinical history: Indicates if the patient experienced an adverse reaction to Renflexis, a preferred biosimilar."
    },
    {
      "name": "CB94",
      "type": "checkbox",
      "page": 3,
      "field_label": "Simponi Aria (golimumab)",
      "question": "Has the patient had an adverse reaction to Simponi Aria (golimumab)?",
      "context": "Clinical history: Indicates if the patient experienced an adverse reaction to Simponi Aria, a preferred biologic."
    },
    {
      "name": "T95",
      "type": "text",
      "page": 3,
      "field_label": "When was the member’s adverse reaction to the preferred drug?",
      "question": "When did the patient's adverse reaction to the preferred drug occur?",
      "context": "Clinical history: Specifies the date of the adverse reaction, crucial for causality and treatment plan adjustments. Dependent on prior checkbox selection."
    },
    {
      "name": "T96a",
      "type": "text",
      "page": 3,
      "field_label": "Please describe the nature of the adverse reaction to the preferred drug",
      "question": "Describe the nature of the patient's adverse reaction to the preferred drug.",
      "context": "Clinical history: Details the type and severity of the adverse reaction to the preferred drug. Dependent on prior checkbox selection."
    },
    {
      "name": "CB91",
      "type": "checkbox",
      "page": 3,
      "field_label": "No",
      "question": "Has the patient NOT had an adverse reaction to any specified rituximab biosimilars?",
      "context": "Clinical history: Indicates if the patient has not experienced adverse reactions to the listed preferred drugs."
    },
    {
      "name": "CB98a",
      "type": "checkbox",
      "page": 3,
      "field_label": "Enbrel (etanercept)",
      "question": "Has the patient had a trial and failure of Enbrel (etanercept)?",
      "context": "Clinical history: Indicates if a trial and failure of Enbrel, a preferred biologic, occurred for this initiation request."
    },
    {
      "name": "CB99a",
      "type": "checkbox",
      "page": 3,
      "field_label": "Humira (adalimumab)",
      "question": "Has the patient had a trial and failure of Humira (adalimumab)?",
      "context": "Clinical history: Indicates if a trial and failure of Humira, a preferred biologic, occurred for this initiation request."
    },
    {
      "name": "CB100a",
      "type": "checkbox",
      "page": 3,
      "field_label": "Idacio (adalimumab-aacf)",
      "question": "Has the patient had a trial and failure of Idacio (adalimumab-aacf)?",
      "context": "Clinical history: Indicates if a trial and failure of Idacio, a preferred biosimilar, occurred for this initiation request."
    },
    {
      "name": "CB101a",
      "type": "checkbox",
      "page": 3,
      "field_label": "Rinvoq (upadacitinib)",
      "question": "Has the patient had a trial and failure of Rinvoq (upadacitinib)?",
      "context": "Clinical history: Indicates if a trial and failure of Rinvoq, a preferred JAK inhibitor, occurred for this initiation request."
    },
    {
      "name": "CB102a",
      "type": "checkbox",
      "page": 3,
      "field_label": "Tyenne SC (tocilizumab-aazg)",
      "question": "Has the patient had a trial and failure of Tyenne SC (tocilizumab-aazg)?",
      "context": "Clinical history: Indicates if a trial and failure of Tyenne SC, a preferred biosimilar, occurred for this initiation request."
    },
    {
      "name": "CB103a",
      "type": "checkbox",
      "page": 3,
      "field_label": "Xeljanz/Xeljanz XR (tofacitinib)",
      "question": "Has the patient had a trial and failure of Xeljanz/Xeljanz XR (tofacitinib)?",
      "context": "Clinical history: Indicates if a trial and failure of Xeljanz/Xeljanz XR, a preferred JAK inhibitor, occurred for this initiation request."
    },
    {
      "name": "T104",
      "type": "text",
      "page": 3,
      "field_label": "When was the member’s trial and failure of the preferred drug?",
      "question": "When did the patient's trial and failure of the preferred drug occur?",
      "context": "Clinical history: Specifies the date of trial and failure, important for assessing recency and treatment progression. Dependent on prior checkbox selection."
    },
    {
      "name": "T105",
      "type": "text",
      "page": 3,
      "field_label": "Please describe the nature of the failure of the preferred drug",
      "question": "Describe the nature of the patient's failure with the preferred drug.",
      "context": "Clinical history: Details why the preferred drug failed (e.g., lack of efficacy, progression). Dependent on prior checkbox selection."
    },
    {
      "name": "CB97",
      "type": "checkbox",
      "page": 3,
      "field_label": "No",
      "question": "Has the patient NOT had a trial and failure of any specified preferred products?",
      "context": "Clinical history: Indicates if the patient has not undergone trial and failure of the listed preferred drugs."
    },
    {
      "name": "CB107z",
      "type": "checkbox",
      "page": 3,
      "field_label": "Enbrel (etanercept)",
      "question": "Has the patient had an adverse reaction to Enbrel (etanercept)?",
      "context": "Clinical history: Indicates if the patient experienced an adverse reaction to Enbrel, a preferred biologic."
    },
    {
      "name": "CB108z",
      "type": "checkbox",
      "page": 3,
      "field_label": "Humira (adalimumab)",
      "question": "Has the patient had an adverse reaction to Humira (adalimumab)?",
      "context": "Clinical history: Indicates if the patient experienced an adverse reaction to Humira, a preferred biologic."
    },
    {
      "name": "CB109z",
      "type": "checkbox",
      "page": 3,
      "field_label": "Idacio (adalimumab-aacf)",
      "question": "Has the patient had an adverse reaction to Idacio (adalimumab-aacf)?",
      "context": "Clinical history: Indicates if the patient experienced an adverse reaction to Idacio, a preferred biosimilar."
    },
    {
      "name": "CB110z",
      "type": "checkbox",
      "page": 3,
      "field_label": "Rinvoq (upadacitinib)",
      "question": "Has the patient had an adverse reaction to Rinvoq (upadacitinib)?",
      "context": "Clinical history: Indicates if the patient experienced an adverse reaction to Rinvoq, a preferred JAK inhibitor."
    },
    {
      "name": "CB111z",
      "type": "checkbox",
      "page": 3,
      "field_label": "Tyenne SC (tocilizumab-aazg)",
      "question": "Has the patient had an adverse reaction to Tyenne SC (tocilizumab-aazg)?",
      "context": "Clinical history: Indicates if the patient experienced an adverse reaction to Tyenne SC, a preferred biosimilar."
    },
    {
      "name": "CB112z",
      "type": "checkbox",
      "page": 3,
      "field_label": "Xeljanz/Xeljanz XR (tofacitinib)",
      "question": "Has the patient had an adverse reaction to Xeljanz/Xeljanz XR (tofacitinib)?",
      "context": "Clinical history: Indicates if the patient experienced an adverse reaction to Xeljanz/Xeljanz XR, a preferred JAK inhibitor."
    },
    {
      "name": "T113",
      "type": "text",
      "page": 3,
      "field_label": "When was the member’s adverse reaction to the preferred drug?",
      "question": "When did the patient's adverse reaction to the preferred drug occur?",
      "context": "Clinical history: Specifies the date of the adverse reaction, crucial for causality and treatment plan adjustments. Dependent on prior checkbox selection."
    },
    {
      "name": "T114",
      "type": "text",
      "page": 3,
      "field_label": "Please describe the nature of the adverse reaction to the preferred drug",
      "question": "Describe the nature of the patient's adverse reaction to the preferred drug.",
      "context": "Clinical history: Details the type and severity of the adverse reaction to the preferred drug. Dependent on prior checkbox selection."
    },
    {
      "name": "CB106z",
      "type": "checkbox",
      "page": 3,
      "field_label": "No",
      "question": "Has the patient NOT had an adverse reaction to any specified preferred products?",
      "context": "Clinical history: Indicates if the patient has not experienced adverse reactions to the listed preferred drugs."
    },
    {
      "name": "T118",
      "type": "text",
      "page": 3,
      "field_label": "Please explain if there are any contraindications or other medical reason(s) that the patient cannot use any of the following preferred products when indicated for the patient’s diagnosis?",
      "question": "Are there medical reasons or contraindications preventing the patient from using the preferred products for their diagnosis?",
      "context": "Clinical justification: Provides medical reasons for not using preferred rituximab biosimilars (Ruxience/Truxima) due to contraindications or other factors."
    },
    {
      "name": "CB115z",
      "type": "checkbox",
      "page": 3,
      "field_label": "Inflectra (infliximab-dyyb)",
      "question": "Is Inflectra (infliximab-dyyb) contraindicated or medically unsuitable for the patient?",
      "context": "Clinical justification: Indicates if Inflectra, a preferred biosimilar, is medically unsuitable or contraindicated for the patient's diagnosis."
    },
    {
      "name": "CB116z",
      "type": "checkbox",
      "page": 3,
      "field_label": "Renflexis (infliximab-abda)",
      "question": "Is Renflexis (infliximab-abda) contraindicated or medically unsuitable for the patient?",
      "context": "Clinical justification: Indicates if Renflexis, a preferred biosimilar, is medically unsuitable or contraindicated for the patient's diagnosis."
    },
    {
      "name": "CB117z",
      "type": "checkbox",
      "page": 3,
      "field_label": "Simponi Aria (golimumab)",
      "question": "Is Simponi Aria (golimumab) contraindicated or medically unsuitable for the patient?",
      "context": "Clinical justification: Indicates if Simponi Aria, a preferred biologic, is medically unsuitable or contraindicated for the patient's diagnosis."
    },
    {
      "name": "T125",
      "type": "text",
      "page": 3,
      "field_label": "Please explain if there are contraindications or any other medical reason(s) that the patient cannot use any of the following preferred products when indicated for the patient’s diagnosis?",
      "question": "Are there medical reasons or contraindications preventing the patient from using the listed preferred products for their diagnosis?",
      "context": "Clinical justification: Provides medical reasons for not using other preferred biologics/JAK inhibitors due to contraindications or other factors."
    },
    {
      "name": "CB119z",
      "type": "checkbox",
      "page": 3,
      "field_label": "Enbrel (etanercept)",
      "question": "Is Enbrel (etanercept) contraindicated or medically unsuitable for the patient?",
      "context": "Clinical justification: Indicates if Enbrel, a preferred biologic, is medically unsuitable or contraindicated for the patient's diagnosis."
    },
    {
      "name": "CB120z",
      "type": "checkbox",
      "page": 3,
      "field_label": "Humira (adalimumab)",
      "question": "Is Humira (adalimumab) contraindicated or medically unsuitable for the patient?",
      "context": "Clinical justification: Indicates if Humira, a preferred biologic, is medically unsuitable or contraindicated for the patient's diagnosis."
    },
    {
      "name": "CB121z",
      "type": "checkbox",
      "page": 3,
      "field_label": "Idacio (adalimumab-aacf)",
      "question": "Is Idacio (adalimumab-aacf) contraindicated or medically unsuitable for the patient?",
      "context": "Clinical justification: Indicates if Idacio, a preferred biosimilar, is medically unsuitable or contraindicated for the patient's diagnosis."
    },
    {
      "name": "CB122z",
      "type": "checkbox",
      "page": 3,
      "field_label": "Rinvoq (upadacitinib)",
      "question": "Is Rinvoq (upadacitinib) contraindicated or medically unsuitable for the patient?",
      "context": "Clinical justification: Indicates if Rinvoq, a preferred JAK inhibitor, is medically unsuitable or contraindicated for the patient's diagnosis."
    },
    {
      "name": "CB123z",
      "type": "checkbox",
      "page": 3,
      "field_label": "Tyenne SC (tocilizumab-aazg)",
      "question": "Is Tyenne SC (tocilizumab-aazg) contraindicated or medically unsuitable for the patient?",
      "context": "Clinical justification: Indicates if Tyenne SC, a preferred biosimilar, is medically unsuitable or contraindicated for the patient's diagnosis."
    },
    {
      "name": "CB124z",
      "type": "checkbox",
      "page": 3,
      "field_label": "Xeljanz/Xeljanz XR (tofacitinib)",
      "question": "Is Xeljanz/Xeljanz XR (tofacitinib) contraindicated or medically unsuitable for the patient?",
      "context": "Clinical justification: Indicates if Xeljanz/Xeljanz XR, a preferred JAK inhibitor, is medically unsuitable or contraindicated for the patient's diagnosis."
    },
    {
      "name": "CB96.4.0",
      "type": "checkbox",
      "page": 3,
      "field_label": "Yes",
      "question": "Will Rituxan (rituximab) be used concomitantly with other specified DMARDs?",
      "context": "Treatment plan: Specifies if Rituxan will be co-administered with other immunosuppressants, crucial for drug interaction assessment."
    },
    {
      "name": "CB98",
      "type": "checkbox",
      "page": 3,
      "field_label": "No",
      "question": "Will Rituxan (rituximab) NOT be used concomitantly with other specified DMARDs?",
      "context": "Treatment plan: Specifies if Rituxan will not be co-administered with other immunosuppressants, crucial for drug interaction assessment."
    },
    {
      "name": "CB99.0",
      "type": "checkbox",
      "page": 3,
      "field_label": "Yes",
      "question": "Does the patient have a documented diagnosis of Philadelphia chromosome-negative acute lymphoid leukemia (ALL)?",
      "context": "Diagnosis verification: Confirms a specific ALL subtype, critical for medical necessity of Rituxan therapy."
    },
    {
      "name": "CB100.0",
      "type": "checkbox",
      "page": 3,
      "field_label": "No",
      "question": "Does the patient NOT have a documented diagnosis of Philadelphia chromosome-negative acute lymphoid leukemia (ALL)?",
      "context": "Diagnosis verification: Confirms absence of a specific ALL subtype, critical for medical necessity of Rituxan therapy."
    },
    {
      "name": "CB101.0",
      "type": "checkbox",
      "page": 3,
      "field_label": "Yes",
      "question": "Is Rituxan (rituximab) being used as induction/consolidation therapy for ALL?",
      "context": "Treatment indication: Specifies the phase of ALL treatment, indicating Rituxan's role in the regimen."
    },
    {
      "name": "CB102.0",
      "type": "checkbox",
      "page": 3,
      "field_label": "No",
      "question": "Is Rituxan (rituximab) NOT being used as induction/consolidation therapy for ALL?",
      "context": "Treatment indication: Specifies the phase of ALL treatment, indicating Rituxan's role in the regimen."
    },
    {
      "name": "CB103",
      "type": "checkbox",
      "page": 3,
      "field_label": "Yes",
      "question": "Does the patient have a documented diagnosis of refractory autoimmune hemolytic anemia?",
      "context": "Diagnosis verification: Confirms a diagnosis of refractory AIHA, a specific indication for Rituxan."
    },
    {
      "name": "CB104",
      "type": "checkbox",
      "page": 3,
      "field_label": "No",
      "question": "Does the patient NOT have a documented diagnosis of refractory autoimmune hemolytic anemia?",
      "context": "Diagnosis verification: Confirms absence of a diagnosis of refractory AIHA, a specific indication for Rituxan."
    },
    {
      "name": "CB104a",
      "type": "checkbox",
      "page": 3,
      "field_label": "Wegener granulomatosis",
      "question": "Does the patient have Wegener granulomatosis (now Granulomatosis with Polyangiitis)?",
      "context": "Specific diagnosis: Indicates a subtype of ANCA-associated vasculitides, crucial for treatment protocol adherence."
    },
    {
      "name": "CB104b",
      "type": "checkbox",
      "page": 3,
      "field_label": "Churg-Strauss syndrome",
      "question": "Does the patient have Churg-Strauss syndrome (now Eosinophilic Granulomatosis with Polyangiitis)?",
      "context": "Specific diagnosis: Indicates a subtype of ANCA-associated vasculitides, crucial for treatment protocol adherence."
    },
    {
      "name": "CB104c",
      "type": "checkbox",
      "page": 3,
      "field_label": "microscopic polyangiitis",
      "question": "Does the patient have microscopic polyangiitis?",
      "context": "Specific diagnosis: Indicates a subtype of ANCA-associated vasculitides, crucial for treatment protocol adherence."
    },
    {
      "name": "CB104d",
      "type": "checkbox",
      "page": 3,
      "field_label": "pauci-immune glomerulonephritis",
      "question": "Does the patient have pauci-immune glomerulonephritis?",
      "context": "Specific diagnosis: Indicates a subtype of ANCA-associated vasculitides, crucial for treatment protocol adherence."
    },
    {
      "name": "CB105",
      "type": "checkbox",
      "page": 3,
      "field_label": "Yes",
      "question": "Will Rituxan (rituximab) be given in conjunction with glucocorticoids?",
      "context": "Treatment plan: Specifies if Rituxan will be co-administered with glucocorticoids, crucial for combination therapy assessment."
    },
    {
      "name": "CB106",
      "type": "checkbox",
      "page": 3,
      "field_label": "No",
      "question": "Will Rituxan (rituximab) NOT be given in conjunction with glucocorticoids?",
      "context": "Treatment plan: Specifies if Rituxan will not be co-administered with glucocorticoids, crucial for combination therapy assessment."
    },
    {
      "name": "CB106a",
      "type": "checkbox",
      "page": 3,
      "field_label": "Yes",
      "question": "Does the patient have a documented diagnosis of corticosteroid-refractory autoimmune blistering disease?",
      "context": "Diagnosis verification: Confirms diagnosis of corticosteroid-refractory autoimmune blistering disease, a specific indication for Rituxan."
    },
    {
      "name": "CB107",
      "type": "checkbox",
      "page": 3,
      "field_label": "pemphigus vulgaris",
      "question": "Does the patient have pemphigus vulgaris?",
      "context": "Specific diagnosis: Identifies the subtype of autoimmune blistering disease for treatment validation."
    },
    {
      "name": "CB108",
      "type": "checkbox",
      "page": 3,
      "field_label": "pemphigus folliaceus",
      "question": "Does the patient have pemphigus folliaceus?",
      "context": "Specific diagnosis: Identifies the subtype of autoimmune blistering disease for treatment validation."
    },
    {
      "name": "CB109",
      "type": "checkbox",
      "page": 3,
      "field_label": "bullous pemphigoid",
      "question": "Does the patient have bullous pemphigoid?",
      "context": "Specific diagnosis: Identifies the subtype of autoimmune blistering disease for treatment validation."
    },
    {
      "name": "CB110",
      "type": "checkbox",
      "page": 3,
      "field_label": "cicatricial pemphigoid",
      "question": "Does the patient have cicatricial pemphigoid?",
      "context": "Specific diagnosis: Identifies the subtype of autoimmune blistering disease for treatment validation."
    },
    {
      "name": "CB111",
      "type": "checkbox",
      "page": 3,
      "field_label": "epidermolysis bullosa acquisita",
      "question": "Does the patient have epidermolysis bullosa acquisita?",
      "context": "Specific diagnosis: Identifies the subtype of autoimmune blistering disease for treatment validation."
    },
    {
      "name": "CB112",
      "type": "checkbox",
      "page": 3,
      "field_label": "paraneoplastic pemphigus",
      "question": "Does the patient have paraneoplastic pemphigus?",
      "context": "Specific diagnosis: Identifies the subtype of autoimmune blistering disease for treatment validation."
    },
    {
      "name": "CB113",
      "type": "checkbox",
      "page": 3,
      "field_label": "None of the above",
      "question": "Does the patient have none of the listed autoimmune blistering diseases?",
      "context": "Specific diagnosis: Indicates that none of the specific autoimmune blistering disease subtypes apply."
    },
    {
      "name": "CB106b",
      "type": "checkbox",
      "page": 3,
      "field_label": "No",
      "question": "Does the patient NOT have a documented diagnosis of corticosteroid-refractory autoimmune blistering disease?",
      "context": "Diagnosis verification: Confirms absence of diagnosis of corticosteroid-refractory autoimmune blistering disease."
    },
    {
      "name": "CB114",
      "type": "checkbox",
      "page": 3,
      "field_label": "AIDS-related B-cell lymphoma",
      "question": "Does the patient have AIDS-related B-cell lymphoma?",
      "context": "Specific diagnosis: Identifies the subtype of B-cell lymphoma, relevant for treatment indication."
    },
    {
      "name": "CB115",
      "type": "checkbox",
      "page": 3,
      "field_label": "Burkitt lymphoma",
      "question": "Does the patient have Burkitt lymphoma?",
      "context": "Specific diagnosis: Identifies the subtype of B-cell lymphoma, relevant for treatment indication."
    },
    {
      "name": "CB116",
      "type": "checkbox",
      "page": 3,
      "field_label": "Diffuse large B-cell lymphoma",
      "question": "Does the patient have Diffuse large B-cell lymphoma?",
      "context": "Specific diagnosis: Identifies the subtype of B-cell lymphoma, relevant for treatment indication."
    },
    {
      "name": "CB117",
      "type": "checkbox",
      "page": 3,
      "field_label": "Follicular lymphoma",
      "question": "Does the patient have Follicular lymphoma?",
      "context": "Specific diagnosis: Identifies the subtype of B-cell lymphoma, relevant for treatment indication."
    },
    {
      "name": "CB118",
      "type": "checkbox",
      "page": 3,
      "field_label": "Gastric MALT lymphoma",
      "question": "Does the patient have Gastric MALT lymphoma?",
      "context": "Specific diagnosis: Identifies the subtype of B-cell lymphoma, relevant for treatment indication."
    },
    {
      "name": "CB119",
      "type": "checkbox",
      "page": 3,
      "field_label": "High-grade B-Cell lymphoma",
      "question": "Does the patient have High-grade B-Cell lymphoma?",
      "context": "Specific diagnosis: Identifies the subtype of B-cell lymphoma, relevant for treatment indication."
    },
    {
      "name": "CB120",
      "type": "checkbox",
      "page": 3,
      "field_label": "Mantle cell lymphoma",
      "question": "Does the patient have Mantle cell lymphoma?",
      "context": "Specific diagnosis: Identifies the subtype of B-cell lymphoma, relevant for treatment indication."
    },
    {
      "name": "CB121",
      "type": "checkbox",
      "page": 3,
      "field_label": "Nodal marginal zone lymphoma",
      "question": "Does the patient have Nodal marginal zone lymphoma?",
      "context": "Specific diagnosis: Identifies the subtype of B-cell lymphoma, relevant for treatment indication."
    },
    {
      "name": "CB122",
      "type": "checkbox",
      "page": 3,
      "field_label": "Nongastric MALT lymphoma",
      "question": "Does the patient have Nongastric MALT lymphoma?",
      "context": "Specific diagnosis: Identifies the subtype of B-cell lymphoma, relevant for treatment indication."
    },
    {
      "name": "CB123",
      "type": "checkbox",
      "page": 3,
      "field_label": "Primary cutaneous B-cell lymphomas",
      "question": "Does the patient have Primary cutaneous B-cell lymphomas?",
      "context": "Specific diagnosis: Identifies the subtype of B-cell lymphoma, relevant for treatment indication."
    },
    {
      "name": "CB124",
      "type": "checkbox",
      "page": 3,
      "field_label": "Splenic marginal zone lymphoma",
      "question": "Does the patient have Splenic marginal zone lymphoma?",
      "context": "Specific diagnosis: Identifies the subtype of B-cell lymphoma, relevant for treatment indication."
    },
    {
      "name": "CB125",
      "type": "checkbox",
      "page": 3,
      "field_label": "Other:",
      "question": "Does the patient have another type of B-cell lymphoma not listed?",
      "context": "Specific diagnosis: Allows for specification of other B-cell lymphoma subtypes not explicitly listed."
    },
    {
      "name": "T126",
      "type": "text",
      "page": 3,
      "field_label": "Other:",
      "question": "Please specify the 'Other' B-cell lymphoma type.",
      "context": "Specific diagnosis: Text field to describe any other B-cell lymphoma subtype if 'Other' is selected."
    }
  ],
  "4": [
    {
      "name": "T12",
      "type": "text",
      "page": 4,
      "field_label": "Patient First Name",
      "question": "What is the patient's first name?",
      "context": "Patient's demographic information for identification purposes on the precertification request."
    },
    {
      "name": "T13",
      "type": "text",
      "page": 4,
      "field_label": "Patient Last Name",
      "question": "What is the patient's last name?",
      "context": "Patient's demographic information for identification purposes on the precertification request."
    },
    {
      "name": "T19",
      "type": "text",
      "page": 4,
      "field_label": "Patient Phone",
      "question": "What is the patient's phone number?",
      "context": "Patient's contact information for communication regarding the precertification request."
    },
    {
      "name": "T14",
      "type": "text",
      "page": 4,
      "field_label": "Patient DOB (MM/DD/YYYY)",
      "question": "What is the patient's date of birth (MM/DD/YYYY)?",
      "context": "Patient's demographic information for identification and age verification."
    },
    {
      "name": "CB127",
      "type": "checkbox",
      "page": 4,
      "field_label": "Yes",
      "question": "Does the patient have a documented diagnosis of multicentric Castleman's disease?",
      "context": "Clinical criteria for Castleman's disease diagnosis, required for treatment approval."
    },
    {
      "name": "CB128",
      "type": "checkbox",
      "page": 4,
      "field_label": "No",
      "question": "Does the patient not have a documented diagnosis of multicentric Castleman's disease?",
      "context": "Indicates absence of Castleman's disease, affecting treatment eligibility."
    },
    {
      "name": "CB129",
      "type": "checkbox",
      "page": 4,
      "field_label": "leptomeningeal metastases from lymphoma",
      "question": "Is the patient's central nervous system lymphoma characterized by leptomeningeal metastases?",
      "context": "Specific subtype of CNS lymphoma, informing treatment approach."
    },
    {
      "name": "CB130",
      "type": "checkbox",
      "page": 4,
      "field_label": "primary CNS lymphoma",
      "question": "Does the patient have primary CNS lymphoma?",
      "context": "Specific subtype of CNS lymphoma, informing treatment approach."
    },
    {
      "name": "CB131",
      "type": "checkbox",
      "page": 4,
      "field_label": "none of the above",
      "question": "Are none of the listed central nervous system lymphoma types applicable to the patient?",
      "context": "Indicates the patient's CNS lymphoma type is not among the specified options."
    },
    {
      "name": "CB132",
      "type": "checkbox",
      "page": 4,
      "field_label": "chronic lymphocytic leukemia (CLL)",
      "question": "Does the patient have chronic lymphocytic leukemia (CLL)?",
      "context": "Specific subtype of leukemia for treatment eligibility assessment."
    },
    {
      "name": "CB133",
      "type": "checkbox",
      "page": 4,
      "field_label": "small lymphocytic leukemia",
      "question": "Does the patient have small lymphocytic leukemia?",
      "context": "Specific subtype of leukemia for treatment eligibility assessment."
    },
    {
      "name": "CB134",
      "type": "checkbox",
      "page": 4,
      "field_label": "none of the above",
      "question": "Are none of the listed chronic or small lymphocytic leukemia types applicable to the patient?",
      "context": "Indicates the patient's leukemia type is not among the specified options."
    },
    {
      "name": "CB135",
      "type": "checkbox",
      "page": 4,
      "field_label": "Yes",
      "question": "Does the patient have a documented diagnosis of cryoglobulinemia?",
      "context": "Clinical criteria for cryoglobulinemia diagnosis, required for treatment approval."
    },
    {
      "name": "CB136",
      "type": "checkbox",
      "page": 4,
      "field_label": "No",
      "question": "Does the patient not have a documented diagnosis of cryoglobulinemia?",
      "context": "Indicates absence of cryoglobulinemia, affecting treatment eligibility."
    },
    {
      "name": "CB139",
      "type": "checkbox",
      "page": 4,
      "field_label": "Yes",
      "question": "Is there clinical documentation that treatment with corticosteroids and other immunosuppressive agents was ineffective for cryoglobulinemia?",
      "context": "Required for prior authorization if standard therapies have failed for cryoglobulinemia."
    },
    {
      "name": "CB140",
      "type": "checkbox",
      "page": 4,
      "field_label": "No",
      "question": "Is there no clinical documentation that treatment with corticosteroids and other immunosuppressive agents was ineffective for cryoglobulinemia?",
      "context": "Indicates if standard therapies have not failed for cryoglobulinemia."
    },
    {
      "name": "CB144",
      "type": "checkbox",
      "page": 4,
      "field_label": "Yes",
      "question": "Is there documentation that Rituxan (rituximab) is being used as last-resort treatment for chronic graft versus host disease (GVHD)?",
      "context": "Indicates the patient's medical necessity for Rituxan after other therapies have failed for GVHD."
    },
    {
      "name": "CB145",
      "type": "checkbox",
      "page": 4,
      "field_label": "No",
      "question": "Is there no documentation that Rituxan (rituximab) is being used as last-resort treatment for chronic graft versus host disease (GVHD)?",
      "context": "Indicates if Rituxan is not being used as a last-resort treatment for GVHD."
    },
    {
      "name": "CB141",
      "type": "checkbox",
      "page": 4,
      "field_label": "relapsed hairy cell leukemia",
      "question": "Does the patient have relapsed hairy cell leukemia?",
      "context": "Specific stage of hairy cell leukemia, affecting treatment protocol."
    },
    {
      "name": "CB142",
      "type": "checkbox",
      "page": 4,
      "field_label": "refractory hairy cell leukemia",
      "question": "Does the patient have refractory hairy cell leukemia?",
      "context": "Specific stage of hairy cell leukemia, affecting treatment protocol."
    },
    {
      "name": "CB143",
      "type": "checkbox",
      "page": 4,
      "field_label": "none of the above",
      "question": "Are none of the listed hairy cell leukemia types applicable to the patient?",
      "context": "Indicates the patient's hairy cell leukemia type is not among the specified options."
    },
    {
      "name": "CB137",
      "type": "checkbox",
      "page": 4,
      "field_label": "Yes",
      "question": "Is there documentation that Rituxan (rituximab) is being used for treatment or prevention of antibody mediated rejection in heart or other solid organ transplant recipients?",
      "context": "Clinical justification for Rituxan use in transplant patients, addressing rejection."
    },
    {
      "name": "CB146",
      "type": "checkbox",
      "page": 4,
      "field_label": "heart transplant recipient",
      "question": "Is the patient a heart transplant recipient?",
      "context": "Specific type of organ transplant, indicating clinical context for Rituxan use."
    },
    {
      "name": "CB147",
      "type": "checkbox",
      "page": 4,
      "field_label": "other solid organ transplant recipient",
      "question": "Is the patient an other solid organ transplant recipient?",
      "context": "Specific type of organ transplant, indicating clinical context for Rituxan use."
    },
    {
      "name": "CB138",
      "type": "checkbox",
      "page": 4,
      "field_label": "No",
      "question": "Is there no documentation that Rituxan (rituximab) is being used for treatment or prevention of antibody mediated rejection in heart or other solid organ transplant recipients?",
      "context": "Indicates if Rituxan is not being used for transplant rejection treatment or prevention."
    },
    {
      "name": "CB148",
      "type": "checkbox",
      "page": 4,
      "field_label": "Bavencio (avelumab)",
      "question": "Was Bavencio (avelumab) the immune checkpoint inhibitor that caused the encephalitis?",
      "context": "Identifies the specific immune checkpoint inhibitor related to the encephalitis."
    },
    {
      "name": "CB149",
      "type": "checkbox",
      "page": 4,
      "field_label": "Imfinzi (durvalumab)",
      "question": "Was Imfinzi (durvalumab) the immune checkpoint inhibitor that caused the encephalitis?",
      "context": "Identifies the specific immune checkpoint inhibitor related to the encephalitis."
    },
    {
      "name": "CB150",
      "type": "checkbox",
      "page": 4,
      "field_label": "Keytruda (pembrolizumab)",
      "question": "Was Keytruda (pembrolizumab) the immune checkpoint inhibitor that caused the encephalitis?",
      "context": "Identifies the specific immune checkpoint inhibitor related to the encephalitis."
    },
    {
      "name": "CB151",
      "type": "checkbox",
      "page": 4,
      "field_label": "Opdivo (nivolumab)",
      "question": "Was Opdivo (nivolumab) the immune checkpoint inhibitor that caused the encephalitis?",
      "context": "Identifies the specific immune checkpoint inhibitor related to the encephalitis."
    },
    {
      "name": "CB152",
      "type": "checkbox",
      "page": 4,
      "field_label": "Tecentriq (atezolizumab)",
      "question": "Was Tecentriq (atezolizumab) the immune checkpoint inhibitor that caused the encephalitis?",
      "context": "Identifies the specific immune checkpoint inhibitor related to the encephalitis."
    },
    {
      "name": "CB153",
      "type": "checkbox",
      "page": 4,
      "field_label": "Yervoy (ipilimumab)",
      "question": "Was Yervoy (ipilimumab) the immune checkpoint inhibitor that caused the encephalitis?",
      "context": "Identifies the specific immune checkpoint inhibitor related to the encephalitis."
    },
    {
      "name": "CB154",
      "type": "checkbox",
      "page": 4,
      "field_label": "Other:",
      "question": "Was an 'Other' immune checkpoint inhibitor the cause of the encephalitis?",
      "context": "Allows specification of an immune checkpoint inhibitor not explicitly listed."
    },
    {
      "name": "T155",
      "type": "text",
      "page": 4,
      "field_label": "Other:",
      "question": "Please specify the 'Other' immune checkpoint inhibitor that caused the encephalitis.",
      "context": "Text field to capture the name of the 'Other' immune checkpoint inhibitor for specificity."
    },
    {
      "name": "CB156",
      "type": "checkbox",
      "page": 4,
      "field_label": "Yes",
      "question": "Does the patient have a documented diagnosis of refractory immune or idiopathic thrombocytopenic purpura (ITP)?",
      "context": "Clinical criteria for ITP diagnosis, crucial for determining treatment necessity."
    },
    {
      "name": "CB158",
      "type": "checkbox",
      "page": 4,
      "field_label": "refractory immune thrombocytopenic purpura",
      "question": "Does the patient have refractory immune thrombocytopenic purpura?",
      "context": "Specific sub-type of ITP, impacting treatment choice and rationale."
    },
    {
      "name": "CB159",
      "type": "checkbox",
      "page": 4,
      "field_label": "idiopathic thrombocytopenic purpura (ITP)",
      "question": "Does the patient have idiopathic thrombocytopenic purpura (ITP)?",
      "context": "Specific sub-type of ITP, impacting treatment choice and rationale."
    },
    {
      "name": "CB157",
      "type": "checkbox",
      "page": 4,
      "field_label": "No",
      "question": "Does the patient not have a documented diagnosis of refractory immune or idiopathic thrombocytopenic purpura (ITP)?",
      "context": "Indicates absence of ITP diagnosis, affecting treatment eligibility."
    },
    {
      "name": "CB160",
      "type": "checkbox",
      "page": 4,
      "field_label": "Yes",
      "question": "Is Rituxan (rituximab) being used as rejection prophylaxis in sensitized kidney transplant recipients with donor specific antibodies?",
      "context": "Indicates Rituxan's use in preventing organ rejection in high-risk kidney transplant patients."
    },
    {
      "name": "CB161",
      "type": "checkbox",
      "page": 4,
      "field_label": "No",
      "question": "Is Rituxan (rituximab) not being used as rejection prophylaxis in sensitized kidney transplant recipients with donor specific antibodies?",
      "context": "Indicates if Rituxan is not being used for kidney transplant rejection prophylaxis."
    },
    {
      "name": "CB162",
      "type": "checkbox",
      "page": 4,
      "field_label": "Yes",
      "question": "Does the patient have a documented diagnosis of lymphocyte-predominant Hodgkin's lymphoma?",
      "context": "Clinical criteria for lymphocyte-predominant Hodgkin's lymphoma, critical for authorization."
    },
    {
      "name": "CB163",
      "type": "checkbox",
      "page": 4,
      "field_label": "No",
      "question": "Does the patient not have a documented diagnosis of lymphocyte-predominant Hodgkin's lymphoma?",
      "context": "Indicates absence of lymphocyte-predominant Hodgkin's lymphoma diagnosis."
    },
    {
      "name": "CB164",
      "type": "checkbox",
      "page": 4,
      "field_label": "Relapsing-remitting MS (RRMS)",
      "question": "Does the patient have Relapsing-remitting MS (RRMS)?",
      "context": "Specific subtype of Multiple Sclerosis, guiding appropriate treatment selection."
    },
    {
      "name": "CB165",
      "type": "checkbox",
      "page": 4,
      "field_label": "Secondary-progressive MS (SPMS)",
      "question": "Does the patient have Secondary-progressive MS (SPMS)?",
      "context": "Specific subtype of Multiple Sclerosis, guiding appropriate treatment selection."
    },
    {
      "name": "CB166",
      "type": "checkbox",
      "page": 4,
      "field_label": "Primary-progressive MS (PPMS)",
      "question": "Does the patient have Primary-progressive MS (PPMS)?",
      "context": "Specific subtype of Multiple Sclerosis, guiding appropriate treatment selection."
    },
    {
      "name": "CB167",
      "type": "checkbox",
      "page": 4,
      "field_label": "Progressive-relapsing MS (PRMS)",
      "question": "Does the patient have Progressive-relapsing MS (PRMS)?",
      "context": "Specific subtype of Multiple Sclerosis, guiding appropriate treatment selection."
    },
    {
      "name": "CB168",
      "type": "checkbox",
      "page": 4,
      "field_label": "Yes",
      "question": "Has the patient discontinued other medications used for treating MS (not including Ampyra)?",
      "context": "Checks for prior medication history for MS, indicating treatment progression or failure."
    },
    {
      "name": "CB169",
      "type": "checkbox",
      "page": 4,
      "field_label": "No",
      "question": "Has the patient not discontinued other medications used for treating MS (not including Ampyra)?",
      "context": "Indicates if previous MS medications are still being used or not discontinued."
    },
    {
      "name": "CB170",
      "type": "checkbox",
      "page": 4,
      "field_label": "Yes",
      "question": "Does the patient have a documented diagnosis of muscle-specific tyrosine kinase myasthenia gravis (MuSK-MG)?",
      "context": "Clinical criteria for MuSK-MG diagnosis, required for treatment approval."
    },
    {
      "name": "CB172",
      "type": "checkbox",
      "page": 4,
      "field_label": "Yes",
      "question": "Has the patient had an unsatisfactory response to initial immunotherapy for MuSK-MG?",
      "context": "Evaluates prior treatment effectiveness for MuSK-MG, justifying alternative therapies."
    },
    {
      "name": "CB173",
      "type": "checkbox",
      "page": 4,
      "field_label": "No",
      "question": "Has the patient not had an unsatisfactory response to initial immunotherapy for MuSK-MG?",
      "context": "Indicates if initial immunotherapy for MuSK-MG was satisfactory."
    },
    {
      "name": "CB171",
      "type": "checkbox",
      "page": 4,
      "field_label": "No",
      "question": "Does the patient not have a documented diagnosis of muscle-specific tyrosine kinase myasthenia gravis (MuSK-MG)?",
      "context": "Indicates absence of MuSK-MG diagnosis, affecting treatment eligibility."
    },
    {
      "name": "CB174",
      "type": "checkbox",
      "page": 4,
      "field_label": "Yes",
      "question": "Does the patient have a documented diagnosis of neuromyelitis optica (Devic's disease)?",
      "context": "Clinical criteria for Devic's disease diagnosis, essential for treatment justification."
    },
    {
      "name": "CB175",
      "type": "checkbox",
      "page": 4,
      "field_label": "No",
      "question": "Does the patient not have a documented diagnosis of neuromyelitis optica (Devic's disease)?",
      "context": "Indicates absence of Devic's disease diagnosis, affecting treatment eligibility."
    },
    {
      "name": "CB176",
      "type": "checkbox",
      "page": 4,
      "field_label": "Yes",
      "question": "Was the treatment with at least one immunotherapy ineffective for neuromyelitis optica?",
      "context": "Evaluates prior treatment effectiveness for Devic's disease, supporting new therapy."
    },
    {
      "name": "CB177",
      "type": "checkbox",
      "page": 4,
      "field_label": "No",
      "question": "Was the treatment with at least one immunotherapy not ineffective for neuromyelitis optica?",
      "context": "Indicates if previous immunotherapy for neuromyelitis optica was effective."
    },
    {
      "name": "CB178",
      "type": "checkbox",
      "page": 4,
      "field_label": "Yes",
      "question": "Does the patient have a documented diagnosis of opsoclonus-myoclonus-ataxia (OMA) associated with neuroblastoma?",
      "context": "Clinical criteria for OMA diagnosis with neuroblastoma, relevant for treatment."
    },
    {
      "name": "CB179",
      "type": "checkbox",
      "page": 4,
      "field_label": "No",
      "question": "Does the patient not have a documented diagnosis of opsoclonus-myoclonus-ataxia (OMA) associated with neuroblastoma?",
      "context": "Indicates absence of OMA diagnosis with neuroblastoma."
    },
    {
      "name": "CB180",
      "type": "checkbox",
      "page": 4,
      "field_label": "Yes",
      "question": "Is the patient refractory to steroids, chemotherapy and intravenous immunoglobulins for OMA?",
      "context": "Indicates failure of standard OMA treatments, justifying alternative or advanced therapy."
    },
    {
      "name": "T189",
      "type": "text",
      "page": 4,
      "field_label": "Medication:",
      "question": "What was the name of the first medication tried for opsoclonus-myoclonus-ataxia?",
      "context": "Name of medication used to treat OMA, providing historical treatment data."
    },
    {
      "name": "T190",
      "type": "text",
      "page": 4,
      "field_label": "Date: (MM)",
      "question": "What is the start month (MM) for the first medication tried for opsoclonus-myoclonus-ataxia?",
      "context": "Start month of the first medication used for OMA, for treatment duration assessment."
    },
    {
      "name": "T191",
      "type": "text",
      "page": 4,
      "field_label": "Date: (DD)",
      "question": "What is the start day (DD) for the first medication tried for opsoclonus-myoclonus-ataxia?",
      "context": "Start day of the first medication used for OMA, for treatment duration assessment."
    },
    {
      "name": "T192",
      "type": "text",
      "page": 4,
      "field_label": "Date: (YYYY)",
      "question": "What is the start year (YYYY) for the first medication tried for opsoclonus-myoclonus-ataxia?",
      "context": "Start year of the first medication used for OMA, for treatment duration assessment."
    },
    {
      "name": "T193",
      "type": "text",
      "page": 4,
      "field_label": "Date: (MM)",
      "question": "What is the end month (MM) for the first medication tried for opsoclonus-myoclonus-ataxia?",
      "context": "End month of the first medication used for OMA, for treatment duration assessment."
    },
    {
      "name": "T194",
      "type": "text",
      "page": 4,
      "field_label": "Date: (DD)",
      "question": "What is the end day (DD) for the first medication tried for opsoclonus-myoclonus-ataxia?",
      "context": "End day of the first medication used for OMA, for treatment duration assessment."
    },
    {
      "name": "T195",
      "type": "text",
      "page": 4,
      "field_label": "Date: (YYYY)",
      "question": "What is the end year (YYYY) for the first medication tried for opsoclonus-myoclonus-ataxia?",
      "context": "End year of the first medication used for OMA, for treatment duration assessment."
    },
    {
      "name": "T196",
      "type": "text",
      "page": 4,
      "field_label": "Medication:",
      "question": "What was the name of the second medication tried for opsoclonus-myoclonus-ataxia?",
      "context": "Name of second medication used to treat OMA, providing historical treatment data."
    },
    {
      "name": "T197",
      "type": "text",
      "page": 4,
      "field_label": "Date: (MM)",
      "question": "What is the start month (MM) for the second medication tried for opsoclonus-myoclonus-ataxia?",
      "context": "Start month of the second medication used for OMA, for treatment duration assessment."
    },
    {
      "name": "T198",
      "type": "text",
      "page": 4,
      "field_label": "Date: (DD)",
      "question": "What is the start day (DD) for the second medication tried for opsoclonus-myoclonus-ataxia?",
      "context": "Start day of the second medication used for OMA, for treatment duration assessment."
    },
    {
      "name": "T199",
      "type": "text",
      "page": 4,
      "field_label": "Date: (YYYY)",
      "question": "What is the start year (YYYY) for the second medication tried for opsoclonus-myoclonus-ataxia?",
      "context": "Start year of the second medication used for OMA, for treatment duration assessment."
    },
    {
      "name": "T200",
      "type": "text",
      "page": 4,
      "field_label": "Date: (MM)",
      "question": "What is the end month (MM) for the second medication tried for opsoclonus-myoclonus-ataxia?",
      "context": "End month of the second medication used for OMA, for treatment duration assessment."
    },
    {
      "name": "T201",
      "type": "text",
      "page": 4,
      "field_label": "Date: (DD)",
      "question": "What is the end day (DD) for the second medication tried for opsoclonus-myoclonus-ataxia?",
      "context": "End day of the second medication used for OMA, for treatment duration assessment."
    },
    {
      "name": "T202",
      "type": "text",
      "page": 4,
      "field_label": "Date: (YYYY)",
      "question": "What is the end year (YYYY) for the second medication tried for opsoclonus-myoclonus-ataxia?",
      "context": "End year of the second medication used for OMA, for treatment duration assessment."
    },
    {
      "name": "CB181",
      "type": "checkbox",
      "page": 4,
      "field_label": "No",
      "question": "Is the patient not refractory to steroids, chemotherapy and intravenous immunoglobulins for OMA?",
      "context": "Indicates if standard OMA treatments (steroids, chemo, IVIG) have been effective."
    },
    {
      "name": "CB203",
      "type": "checkbox",
      "page": 4,
      "field_label": "Yes",
      "question": "Is Rituxan (rituximab) being used as treatment of post-transplant lymphoproliferative disorder?",
      "context": "Justifies Rituxan use for treating PTLD, ensuring medical necessity."
    },
    {
      "name": "CB204",
      "type": "checkbox",
      "page": 4,
      "field_label": "No",
      "question": "Is Rituxan (rituximab) not being used as treatment of post-transplant lymphoproliferative disorder?",
      "context": "Indicates if Rituxan is not being used to treat post-transplant lymphoproliferative disorder."
    },
    {
      "name": "CB205",
      "type": "checkbox",
      "page": 4,
      "field_label": "Yes",
      "question": "Is Rituxan (rituximab) being used as prophylaxis for Epstein-Barr virus (EBV) post-transplant lymphoproliferative disorder?",
      "context": "Justifies Rituxan use for preventing EBV-associated PTLD, ensuring medical necessity."
    },
    {
      "name": "CB206",
      "type": "checkbox",
      "page": 4,
      "field_label": "No",
      "question": "Is Rituxan (rituximab) not being used as prophylaxis for Epstein-Barr virus (EBV) post-transplant lymphoproliferative disorder?",
      "context": "Indicates if Rituxan is not being used for EBV-related PTLD prophylaxis."
    }
  ],
  "5": [
    {
      "name": "T12",
      "type": "text",
      "page": 5,
      "field_label": "Patient First Name",
      "question": "What is the patient's first name?",
      "context": "Patient identification in the Patient Information section, essential for accurate record matching and verification."
    },
    {
      "name": "T13",
      "type": "text",
      "page": 5,
      "field_label": "Patient Last Name",
      "question": "What is the patient's last name?",
      "context": "Patient identification in the Patient Information section, crucial for accurate record matching and verification."
    },
    {
      "name": "T19",
      "type": "text",
      "page": 5,
      "field_label": "Patient Phone",
      "question": "What is the patient's phone number?",
      "context": "Patient contact information in the Patient Information section for communication regarding the request."
    },
    {
      "name": "T14",
      "type": "text",
      "page": 5,
      "field_label": "Patient DOB (MM/DD/YYYY)",
      "question": "What is the patient's date of birth (MM/DD/YYYY)?",
      "context": "Patient identification in the Patient Information section, vital for age-based criteria and accurate record matching."
    },
    {
      "name": "CB207",
      "type": "checkbox",
      "page": 5,
      "field_label": "Mild",
      "question": "Is the patient's rheumatoid arthritis disease severity mild?",
      "context": "Clinical information for Rheumatoid Arthritis, used to assess disease severity at the time of the request."
    },
    {
      "name": "CB208",
      "type": "checkbox",
      "page": 5,
      "field_label": "Moderate",
      "question": "Is the patient's rheumatoid arthritis disease severity moderate?",
      "context": "Clinical information for Rheumatoid Arthritis, used to assess disease severity at the time of the request."
    },
    {
      "name": "CB209",
      "type": "checkbox",
      "page": 5,
      "field_label": "Severe",
      "question": "Is the patient's rheumatoid arthritis disease severity severe?",
      "context": "Clinical information for Rheumatoid Arthritis, used to assess disease severity at the time of the request."
    },
    {
      "name": "CB210",
      "type": "checkbox",
      "page": 5,
      "field_label": "Yes",
      "question": "Is there evidence that the rheumatoid arthritis disease is active?",
      "context": "Primary clinical question for Rheumatoid Arthritis, indicating active disease state justifying treatment."
    },
    {
      "name": "CB211",
      "type": "checkbox",
      "page": 5,
      "field_label": "No",
      "question": "Is there no evidence that the rheumatoid arthritis disease is active?",
      "context": "Primary clinical question for Rheumatoid Arthritis, indicating no active disease state."
    },
    {
      "name": "CB212",
      "type": "checkbox",
      "page": 5,
      "field_label": "Yes",
      "question": "Will Rituxan (rituximab) be used in combination with methotrexate?",
      "context": "Sub-question for Rheumatoid Arthritis regarding concomitant therapy with methotrexate."
    },
    {
      "name": "CB213",
      "type": "checkbox",
      "page": 5,
      "field_label": "No",
      "question": "Will Rituxan (rituximab) not be used in combination with methotrexate?",
      "context": "Sub-question for Rheumatoid Arthritis regarding concomitant therapy with methotrexate."
    },
    {
      "name": "CB214",
      "type": "checkbox",
      "page": 5,
      "field_label": "Yes",
      "question": "Was treatment with methotrexate ineffective, not tolerated or contraindicated?",
      "context": "Sub-question for Rheumatoid Arthritis, assessing the outcome of prior methotrexate therapy."
    },
    {
      "name": "CB216",
      "type": "checkbox",
      "page": 5,
      "field_label": "ineffective",
      "question": "Was methotrexate treatment ineffective?",
      "context": "Reason for methotrexate failure in Rheumatoid Arthritis, determining eligibility for Rituxan based on prior therapy response."
    },
    {
      "name": "CB217",
      "type": "checkbox",
      "page": 5,
      "field_label": "not tolerated",
      "question": "Was methotrexate treatment not tolerated?",
      "context": "Reason for methotrexate failure in Rheumatoid Arthritis, determining eligibility for Rituxan based on patient tolerance."
    },
    {
      "name": "CB218",
      "type": "checkbox",
      "page": 5,
      "field_label": "contraindicated",
      "question": "Was methotrexate treatment contraindicated?",
      "context": "Reason for methotrexate failure in Rheumatoid Arthritis, determining eligibility for Rituxan based on contraindications."
    },
    {
      "name": "CB215",
      "type": "checkbox",
      "page": 5,
      "field_label": "No",
      "question": "Was methotrexate treatment not ineffective, tolerated, or not contraindicated?",
      "context": "Sub-question for Rheumatoid Arthritis, indicating no issues with prior methotrexate therapy."
    },
    {
      "name": "CB223",
      "type": "checkbox",
      "page": 5,
      "field_label": "Yes",
      "question": "Was treatment with another conventional DMARD ineffective?",
      "context": "Sub-question for Rheumatoid Arthritis, assessing the outcome of prior conventional DMARD therapy."
    },
    {
      "name": "CB225",
      "type": "checkbox",
      "page": 5,
      "field_label": "azathioprine",
      "question": "Was azathioprine an ineffective conventional DMARD?",
      "context": "Specific conventional DMARD failed for Rheumatoid Arthritis, influencing approval for Rituxan."
    },
    {
      "name": "CB226",
      "type": "checkbox",
      "page": 5,
      "field_label": "cyclosporine",
      "question": "Was cyclosporine an ineffective conventional DMARD?",
      "context": "Specific conventional DMARD failed for Rheumatoid Arthritis, influencing approval for Rituxan."
    },
    {
      "name": "CB227",
      "type": "checkbox",
      "page": 5,
      "field_label": "hydroxychloroquine",
      "question": "Was hydroxychloroquine an ineffective conventional DMARD?",
      "context": "Specific conventional DMARD failed for Rheumatoid Arthritis, influencing approval for Rituxan."
    },
    {
      "name": "CB228",
      "type": "checkbox",
      "page": 5,
      "field_label": "leflunomide",
      "question": "Was leflunomide an ineffective conventional DMARD?",
      "context": "Specific conventional DMARD failed for Rheumatoid Arthritis, influencing approval for Rituxan."
    },
    {
      "name": "CB229",
      "type": "checkbox",
      "page": 5,
      "field_label": "sulfasalazine",
      "question": "Was sulfasalazine an ineffective conventional DMARD?",
      "context": "Specific conventional DMARD failed for Rheumatoid Arthritis, influencing approval for Rituxan."
    },
    {
      "name": "CB224",
      "type": "checkbox",
      "page": 5,
      "field_label": "No",
      "question": "Was treatment with another conventional DMARD not ineffective?",
      "context": "Sub-question for Rheumatoid Arthritis, indicating no issues with other conventional DMARD therapy."
    },
    {
      "name": "CB281",
      "type": "checkbox",
      "page": 5,
      "field_label": "Yes",
      "question": "Does the patient have a documented diagnosis of Sjögren's syndrome?",
      "context": "Primary clinical question for Sjögren syndrome, confirming the patient's diagnosis."
    },
    {
      "name": "CB282",
      "type": "checkbox",
      "page": 5,
      "field_label": "No",
      "question": "Does the patient not have a documented diagnosis of Sjögren's syndrome?",
      "context": "Primary clinical question for Sjögren syndrome, confirming absence of diagnosis."
    },
    {
      "name": "CB283",
      "type": "checkbox",
      "page": 5,
      "field_label": "Yes",
      "question": "Was treatment with corticosteroids and other immunosuppressive agents ineffective for Sjögren's syndrome?",
      "context": "Sub-question for Sjögren syndrome, assessing prior therapy response to standard agents."
    },
    {
      "name": "T285",
      "type": "text",
      "page": 5,
      "field_label": "Medication:",
      "question": "What is the name of the corticosteroid or immunosuppressive agent that was used?",
      "context": "Details for Sjögren syndrome, specifying the prior medication that was ineffective."
    },
    {
      "name": "T286",
      "type": "text",
      "page": 5,
      "field_label": "Date: (MM)",
      "question": "What is the month of administration for the first specified medication?",
      "context": "Date of administration for failed Sjögren's medication, detailing the timeline of prior therapy."
    },
    {
      "name": "T287",
      "type": "text",
      "page": 5,
      "field_label": "Date: (DD)",
      "question": "What is the day of administration for the first specified medication?",
      "context": "Date of administration for failed Sjögren's medication, detailing the timeline of prior therapy."
    },
    {
      "name": "T288",
      "type": "text",
      "page": 5,
      "field_label": "Date: (YYYY)",
      "question": "What is the year of administration for the first specified medication?",
      "context": "Date of administration for failed Sjögren's medication, detailing the timeline of prior therapy."
    },
    {
      "name": "T289",
      "type": "text",
      "page": 5,
      "field_label": "Date: (MM)",
      "question": "What is the month of administration for the second specified medication?",
      "context": "Date of administration for failed Sjögren's medication, detailing the timeline of prior therapy."
    },
    {
      "name": "T290",
      "type": "text",
      "page": 5,
      "field_label": "Date: (DD)",
      "question": "What is the day of administration for the second specified medication?",
      "context": "Date of administration for failed Sjögren's medication, detailing the timeline of prior therapy."
    },
    {
      "name": "T291",
      "type": "text",
      "page": 5,
      "field_label": "Date: (YYYY)",
      "question": "What is the year of administration for the second specified medication?",
      "context": "Date of administration for failed Sjögren's medication, detailing the timeline of prior therapy."
    },
    {
      "name": "T292",
      "type": "text",
      "page": 5,
      "field_label": "Medication:",
      "question": "What is the name of the second corticosteroid or immunosuppressive agent that was used?",
      "context": "Details for Sjögren syndrome, specifying the second prior medication that was ineffective."
    },
    {
      "name": "T293",
      "type": "text",
      "page": 5,
      "field_label": "Date: (MM)",
      "question": "What is the month of administration for the third specified medication?",
      "context": "Date of administration for failed Sjögren's medication, detailing the timeline of prior therapy."
    },
    {
      "name": "T294",
      "type": "text",
      "page": 5,
      "field_label": "Date: (DD)",
      "question": "What is the day of administration for the third specified medication?",
      "context": "Date of administration for failed Sjögren's medication, detailing the timeline of prior therapy."
    },
    {
      "name": "T295",
      "type": "text",
      "page": 5,
      "field_label": "Date: (YYYY)",
      "question": "What is the year of administration for the third specified medication?",
      "context": "Date of administration for failed Sjögren's medication, detailing the timeline of prior therapy."
    },
    {
      "name": "T296",
      "type": "text",
      "page": 5,
      "field_label": "Date: (MM)",
      "question": "What is the month of administration for the fourth specified medication?",
      "context": "Date of administration for failed Sjögren's medication, detailing the timeline of prior therapy."
    },
    {
      "name": "T297",
      "type": "text",
      "page": 5,
      "field_label": "Date: (DD)",
      "question": "What is the day of administration for the fourth specified medication?",
      "context": "Date of administration for failed Sjögren's medication, detailing the timeline of prior therapy."
    },
    {
      "name": "T298",
      "type": "text",
      "page": 5,
      "field_label": "Date: (YYYY)",
      "question": "What is the year of administration for the fourth specified medication?",
      "context": "Date of administration for failed Sjögren's medication, detailing the timeline of prior therapy."
    },
    {
      "name": "CB284",
      "type": "checkbox",
      "page": 5,
      "field_label": "No",
      "question": "Was treatment with corticosteroids and other immunosuppressive agents not ineffective for Sjögren's syndrome?",
      "context": "Sub-question for Sjögren syndrome, indicating prior therapy with standard agents was effective."
    },
    {
      "name": "CB299",
      "type": "checkbox",
      "page": 5,
      "field_label": "Yes",
      "question": "Does the patient have a documented diagnosis of refractory thrombotic thrombocytopenic purpura (TTP)?",
      "context": "Primary clinical question for TTP, confirming diagnosis for potential Rituxan use."
    },
    {
      "name": "CB300",
      "type": "checkbox",
      "page": 5,
      "field_label": "No",
      "question": "Does the patient not have a documented diagnosis of refractory thrombotic thrombocytopenic purpura (TTP)?",
      "context": "Primary clinical question for TTP, indicating absence of diagnosis for Rituxan coverage."
    },
    {
      "name": "CB301",
      "type": "checkbox",
      "page": 5,
      "field_label": "Yes",
      "question": "Does the patient have a documented diagnosis of Waldenström macroglobulinemia?",
      "context": "Primary clinical question for Waldenström's macroglobulinemia, confirming diagnosis for Rituxan coverage."
    },
    {
      "name": "CB302",
      "type": "checkbox",
      "page": 5,
      "field_label": "No",
      "question": "Does the patient not have a documented diagnosis of Waldenström macroglobulinemia?",
      "context": "Primary clinical question for Waldenström's macroglobulinemia, indicating absence of diagnosis."
    },
    {
      "name": "CB303",
      "type": "checkbox",
      "page": 5,
      "field_label": "Yes",
      "question": "Is this continuation request a result of the patient receiving samples of Rituxan (rituximab)?",
      "context": "Continuation request detail, clarifying if the current therapy started with sample medication."
    },
    {
      "name": "CB304",
      "type": "checkbox",
      "page": 5,
      "field_label": "No",
      "question": "Is this continuation request not a result of the patient receiving samples of Rituxan (rituximab)?",
      "context": "Continuation request detail, clarifying if the current therapy did not start with sample medication."
    },
    {
      "name": "T305",
      "type": "text",
      "page": 5,
      "field_label": "Please indicate the length of time on Rituxan (rituximab):",
      "question": "What is the length of time the patient has been on Rituxan (rituximab)?",
      "context": "Continuation request detail, specifying duration of current Rituxan therapy for ongoing approval."
    },
    {
      "name": "CB310",
      "type": "checkbox",
      "page": 5,
      "field_label": "Mild",
      "question": "Was the severity of the rheumatoid arthritis disease at baseline (pretreatment with Rituxan (rituximab)) mild?",
      "context": "Baseline severity assessment for Rheumatoid Arthritis in continuation requests, used to track treatment efficacy."
    },
    {
      "name": "CB311",
      "type": "checkbox",
      "page": 5,
      "field_label": "Moderate",
      "question": "Was the severity of the rheumatoid arthritis disease at baseline (pretreatment with Rituxan (rituximab)) moderate?",
      "context": "Baseline severity assessment for Rheumatoid Arthritis in continuation requests, used to track treatment efficacy."
    },
    {
      "name": "CB312",
      "type": "checkbox",
      "page": 5,
      "field_label": "Severe",
      "question": "Was the severity of the rheumatoid arthritis disease at baseline (pretreatment with Rituxan (rituximab)) severe?",
      "context": "Baseline severity assessment for Rheumatoid Arthritis in continuation requests, used to track treatment efficacy."
    },
    {
      "name": "CB306",
      "type": "checkbox",
      "page": 5,
      "field_label": "Yes",
      "question": "Is there clinical documentation supporting disease stability for rheumatoid arthritis?",
      "context": "Clinical information for Rheumatoid Arthritis continuation, assessing if disease stability is documented."
    },
    {
      "name": "CB307",
      "type": "checkbox",
      "page": 5,
      "field_label": "No",
      "question": "Is there no clinical documentation supporting disease stability for rheumatoid arthritis?",
      "context": "Clinical information for Rheumatoid Arthritis continuation, assessing if disease stability is documented."
    },
    {
      "name": "CB308",
      "type": "checkbox",
      "page": 5,
      "field_label": "Yes",
      "question": "Is there clinical documentation supporting disease improvement for rheumatoid arthritis?",
      "context": "Clinical information for Rheumatoid Arthritis continuation, assessing if disease improvement is documented."
    },
    {
      "name": "CB309",
      "type": "checkbox",
      "page": 5,
      "field_label": "No",
      "question": "Is there no clinical documentation supporting disease improvement for rheumatoid arthritis?",
      "context": "Clinical information for Rheumatoid Arthritis continuation, assessing if disease improvement is documented."
    },
    {
      "name": "CB313",
      "type": "checkbox",
      "page": 5,
      "field_label": "Yes",
      "question": "Is there clinical documentation supporting disease stability for all other indications?",
      "context": "Clinical information for other indications continuation, assessing if disease stability is documented."
    },
    {
      "name": "CB314",
      "type": "checkbox",
      "page": 5,
      "field_label": "No",
      "question": "Is there no clinical documentation supporting disease stability for all other indications?",
      "context": "Clinical information for other indications continuation, assessing if disease stability is documented."
    },
    {
      "name": "CB315",
      "type": "checkbox",
      "page": 5,
      "field_label": "Yes",
      "question": "Is there clinical documentation supporting disease improvement for all other indications?",
      "context": "Clinical information for other indications continuation, assessing if disease improvement is documented."
    },
    {
      "name": "CB316",
      "type": "checkbox",
      "page": 5,
      "field_label": "No",
      "question": "Is there no clinical documentation supporting disease improvement for all other indications?",
      "context": "Clinical information for other indications continuation, assessing if disease improvement is documented."
    },
    {
      "name": "T317",
      "type": "text",
      "page": 5,
      "field_label": "Date: (MM)",
      "question": "What is the month the request was completed?",
      "context": "Request completion date in the Acknowledgment section, indicating when the form was finalized and signed."
    },
    {
      "name": "T318",
      "type": "text",
      "page": 5,
      "field_label": "Date: (DD)",
      "question": "What is the day the request was completed?",
      "context": "Request completion date in the Acknowledgment section, indicating when the form was finalized and signed."
    },
    {
      "name": "T319",
      "type": "text",
      "page": 5,
      "field_label": "Date: (YYYY)",
      "question": "What is the year the request was completed?",
      "context": "Request completion date in the Acknowledgment section, indicating when the form was finalized and signed."
    }
  ]
}